Loading...
To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?
BACKGROUND: One of the major advantages of dalbavancin is that it may be administered as a single dose for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Our objective was to determine the number (%) of patients with an ABSSSI diagnosis whose admission to a county hosp...
Na minha lista:
| Udgivet i: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5631683/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.802 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|